• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Poorly versus moderately differentiated hepatocellular carcinoma: vascularity assessment by computed tomographic hepatic angiography in correlation with histologically counted number of unpaired arteries.

作者信息

Asayama Yoshiki, Yoshimitsu Kengo, Irie Hiroyuki, Nishihara Yunosuke, Aishima Shinichi, Tajima Tsuyoshi, Hirakawa Masakazu, Ishigami Kousei, Kakihara Daisuke, Taketomi Akinobu, Honda Hiroshi

机构信息

Department of Clinical Radiology, Kyushu University, Higashi-ku, Fukuoka, Japan.

出版信息

J Comput Assist Tomogr. 2007 Mar-Apr;31(2):188-92. doi: 10.1097/01.rct.0000236417.82395.57.

DOI:10.1097/01.rct.0000236417.82395.57
PMID:17414751
Abstract

PURPOSE

To determine the vascularity of moderately and poorly differentiated hepatocellular carcinoma (mHCC and pHCC, respectively) as observed on and depicted by computed tomography during hepatic angiography and to perform pathological correlation.

MATERIALS AND METHODS

Eighty-seven consecutive patients with 89 hepatocellular carcinomas (61 mHCCs and 28 pHCCs) were surgically resected in our hospital. The degree of contrast enhancement on computed tomography during hepatic angiography of the tumors was classified into high attenuation (H), isoattenuation (I), and low attenuation (L). We also examined hepatocellular carcinomas measuring less than 4 cm in diameter. Pathologically, the number of unpaired arteries in the tumors was determined (x200 magnification).

RESULTS

The number of mHCC and pHCC in each degree of enhancement (H/I/L) was 59:1:1 and 19:6:3, respectively. The number of mHCC and pHCC measuring less than 4 cm without portal invasion was 48 and 15, respectively; the number of these tumors in each degree of enhancement (H/I/L) was 47:1:0 and 11:3:1, respectively. The mean number of unpaired arteries was 8.9 +/- 4.4 in mHCC and 5.2 +/- 4.3 in pHCC, respectively. All results were statistically significant (P < 0.01).

CONCLUSIONS

Our results indicated that the arterial blood supply of pHCC was lower than that of mHCC.

摘要

相似文献

1
Poorly versus moderately differentiated hepatocellular carcinoma: vascularity assessment by computed tomographic hepatic angiography in correlation with histologically counted number of unpaired arteries.
J Comput Assist Tomogr. 2007 Mar-Apr;31(2):188-92. doi: 10.1097/01.rct.0000236417.82395.57.
2
Vascular changes in hepatocellular carcinoma: correlation of radiologic and pathologic findings.肝细胞癌中的血管变化:放射学与病理学发现的相关性
AJR Am J Roentgenol. 1999 Nov;173(5):1213-7. doi: 10.2214/ajr.173.5.10541091.
3
Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation.肝细胞癌的动脉血供与组织学分级:影像学-病理学相关性
AJR Am J Roentgenol. 2008 Jan;190(1):W28-34. doi: 10.2214/AJR.07.2117.
4
Tumor attenuation and quantitative analysis of perfusion parameters derived from tri-phasic CT scans in hepatocellular carcinoma: Relationship with histological grade.肝细胞癌三相CT扫描中肿瘤衰减及灌注参数的定量分析:与组织学分级的关系
Medicine (Baltimore). 2021 Apr 23;100(16):e25627. doi: 10.1097/MD.0000000000025627.
5
Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation.肝细胞癌和发育异常结节的序贯血流动力学变化:CT血管造影与病理对照
AJR Am J Roentgenol. 2002 Apr;178(4):885-97. doi: 10.2214/ajr.178.4.1780885.
6
Recent developments in imaging diagnostics for HCC: CT arteriography and CT arterioportography evaluation of vascular changes in premalignant and malignant hepatic nodules.肝癌成像诊断的最新进展:CT动脉造影和CT动脉门静脉造影对癌前和恶性肝结节血管变化的评估
J Hepatobiliary Pancreat Surg. 2000;7(3):245-51. doi: 10.1007/s005340070044.
7
Assessment of arterial tumor vascularity in small hepatocellular carcinoma. Comparison between color doppler ultrasonography and radiographic imagings with contrast medium: dynamic CT, angiography, and CT hepatic arteriography.
Eur J Radiol. 2000 Oct;36(1):20-7. doi: 10.1016/s0720-048x(00)00185-6.
8
Double phase CT during hepatic arteriography for diagnosis of hepatocellular carcinoma.肝动脉造影期间的双期CT用于肝细胞癌的诊断。
Eur J Radiol. 2005 May;54(2):246-52. doi: 10.1016/j.ejrad.2004.05.013.
9
Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation.直径小于 3 厘米的肝细胞癌的多期 MDCT 增强模式:肿瘤大小和细胞分化。
AJR Am J Roentgenol. 2009 Dec;193(6):W482-9. doi: 10.2214/AJR.08.1818.
10
[CT arteriography of hepatic tumors].[肝脏肿瘤的CT血管造影术]
Nihon Igaku Hoshasen Gakkai Zasshi. 1999 Aug;59(9):435-40.

引用本文的文献

1
Large well-differentiated hepatocellular carcinoma in patients with HBV: gadoxetic acid-enhanced MR imaging features and prognosis.乙型肝炎病毒感染患者的大的高分化肝细胞癌:钆塞酸二钠增强磁共振成像特征及预后
Eur Radiol. 2025 Sep 12. doi: 10.1007/s00330-025-11994-3.
2
The correlation between contrast-enhanced ultrasound Liver Imaging Reporting and Data System classification and differentiation grades of combined hepatocellular carcinoma-cholangiocarcinoma.超声造影肝脏影像报告和数据系统分类与肝细胞癌-胆管癌合并症分化程度之间的相关性
Quant Imaging Med Surg. 2025 Jan 2;15(1):259-271. doi: 10.21037/qims-24-1483. Epub 2024 Dec 23.
3
Development and validation of a digital biopsy model to predict microvascular invasion in hepatocellular carcinoma.
一种用于预测肝细胞癌微血管侵犯的数字活检模型的开发与验证
Front Oncol. 2024 Sep 17;14:1360936. doi: 10.3389/fonc.2024.1360936. eCollection 2024.
4
Advances in Understanding Hepatocellular Carcinoma Vasculature: Implications for Diagnosis, Prognostication, and Treatment.肝细胞癌血管生成的研究进展:对诊断、预后和治疗的影响。
Korean J Radiol. 2024 Oct;25(10):887-901. doi: 10.3348/kjr.2024.0307.
5
Liver MRI and clinical findings to predict response after drug eluting bead transarterial chemoembolization in hepatocellular carcinoma.肝脏 MRI 和临床发现预测肝癌经载药微球动脉化疗栓塞治疗后的反应。
Sci Rep. 2021 Dec 15;11(1):24076. doi: 10.1038/s41598-021-01839-6.
6
Deep Learning Predicts Overall Survival of Patients With Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization Plus Sorafenib.深度学习预测经动脉化疗栓塞联合索拉非尼治疗的不可切除肝细胞癌患者的总生存期。
Front Oncol. 2020 Sep 30;10:593292. doi: 10.3389/fonc.2020.593292. eCollection 2020.
7
Predictive imaging for tumor response to drug-eluting microsphere transarterial chemoembolization in patients with BCLC-C advanced hepatocellular carcinoma.预测药物洗脱微球经导管动脉化疗栓塞治疗巴塞罗那临床肝癌分期 C 期晚期肝癌患者的肿瘤反应的影像学方法。
Sci Rep. 2019 Dec 27;9(1):20032. doi: 10.1038/s41598-019-56545-1.
8
Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System.印度国家肝脏研究协会和印度放射与影像协会关于肝细胞癌诊断与成像的联合共识声明,纳入肝脏影像报告和数据系统
J Clin Exp Hepatol. 2019 Sep-Oct;9(5):625-651. doi: 10.1016/j.jceh.2019.07.005. Epub 2019 Aug 6.
9
Angiogenesis of hepatocellular carcinoma: An immunohistochemistry study.肝细胞癌的血管生成:一项免疫组织化学研究。
World J Hepatol. 2019 Mar 27;11(3):294-304. doi: 10.4254/wjh.v11.i3.294.
10
Preliminary study of apparent diffusion coefficient assessment after ion beam therapy for hepatocellular carcinoma.离子束治疗肝细胞癌后表观扩散系数评估的初步研究。
Radiol Phys Technol. 2016 Jul;9(2):233-9. doi: 10.1007/s12194-016-0354-5. Epub 2016 Apr 7.